XML 79 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity (Awards) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation cost $ 45.4    
Weighted average period costs expected to be recognized (in years) 3 years 6 months    
Stock Options and Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant date fair value of Stock options & SARs (in dollars per share) $ 42.47 $ 22.62 $ 20.59
Expected stock price volatility (percent) 39.27% 26.89% 26.59%
Risk-free interest rate (percent) 0.81% 0.89% 2.58%
Expected annual dividend yield (percent) 0.64% 0.82% 1.08%
Expected term of option & SARs (in years) 5 years 6 months 5 years 6 months 5 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Number of shares outstanding, Beginning Balance 3,336    
Number of shares, Granted 701    
Number of shares, Forfeited (177)    
Number of shares, Exercised (596)    
Number of shares outstanding, Ending Balance 3,264 3,336  
Number of shares, Exercisable 1,284    
Number of shares, Stock options & SARs expected to vest 1,980    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted average exercise price, Beginning Balance (in dollars per share) $ 66.76    
Weighted average exercise price, Granted (in dollars per share) 123.21    
Weighted average exercise price, Forfeited (in dollars per share) 82.35    
Weighted average exercise price, Exercised (in dollars per share) 51.59    
Weighted average exercise price, Ending Balance (in dollars per share) 80.79 $ 66.76  
Exercisable, Weighted Average Exercise Price (in dollars per share) 59.40    
Stock options & SARs expected to vest, Weighted Average Exercise Price (in dollars per share) $ 94.67    
Weighted average remaining contractual term, options outstanding (in years) 7 years    
Weighted average remaining contractual term, options exercisable (in years) 5 years 6 months    
Aggregate intrinsic value, options outstanding $ 199.0    
Aggregate intrinsic value, options exercisable 105.8    
Aggregate intrinsic value $ 49.2 $ 26.6 $ 17.0
Restricted Stock Units (RSUs) and Performance Share Units (PSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Number of shares outstanding, Beginning Balance 61    
Number of shares, Granted 21    
Number of shares, Vested (30)    
Number of shares, Forfeited (1)    
Number of shares outstanding, Ending Balance 51 61  
Share-based Compensation Arrangement by Share-based Payment Award, Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average grant date fair value, Beginning Balance (in dollars per share) $ 77.03    
Weighted average grant date fair value, Granted (in dollars per share) 129.94 $ 85.45 $ 78.64
Weighted average grant date fair value, Vested (in dollars per share) 73.11    
Weighted average grant date fair value, Forfeited (in dollars per share) 55.96    
Weighted average grant date fair value, Ending Balance (in dollars per share) $ 101.55 $ 77.03  
Total fair value of shares vested $ 2.2 $ 6.2 $ 2.8